Helen has been documenting her mum’s experience with vascular dementia to raise awareness of the disease. Helen has been documenting her mum’s experience with vascular dementia to raise awareness of ...

Stifel initiated coverage of Structure Therapeutics (GPCR) with a Buy rating and $50 price target Structure aims to expand the reach of metabolic treatments across the large, heterogeneous obesity ...

THE CAUSE OF THE FIRE IS STILL UNDER INVESTIGATION, AND WE’LL KEEP YOU UPDATED BOTH The Omaha Fire Department responded to a structure fire near a recycling plant at 103rd and I Streets early ...

Yes, I used to write this article on the OtterTune blog, but the company is dead (RIP). I'm doing this joint on my professor blog. There is much to cover from the past year, from 10-figure ...

The biggest issues confronting the global economy drew the broadest interest among IMF blog readers around the world this year. Artificial intelligence attracted the greatest interest, making the ...

A study of nearly 10,000 adolescents has identified distinct differences in the brain structures of those who used substances before age 15 compared to those who did not. Many of these structural ...

OpenAI has detailed its plans for a new corporate structure that would separate its business from being controlled by its nonprofit board. In a blog post shared by the company on social media on ...

Published on Dec. 12, 2009, the blog post was made to look like a newspaper article. The New York Times ... to prevent women from coming forward. For example, he wrote, Tal and Oren Alexander ...

Under the proposed plan, the ChatGPT maker's existing for-profit arm would become a Delaware-based public benefit corporation (PBC) - a structure ... OpenAI said in a blog post, adding that ...

With recent advances in molecular medicine and disease treatment in osteoporosis, quantitative image processing of three-dimensional bone structures is critical in the context of bone quality ...

Structure Therapeutics Inc. has announced the selection of its lead oral small molecule amylin receptor agonist, ACCG-2671, which shows promising preclinical results including potent target ...